Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE)

September 24, 2025 updated by: Kevin Borrup

Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE)

The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) in an effort to reduce levels of violence exposure.

Study Overview

Detailed Description

The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) when they are determined to have high levels of violence exposure.

SCOPE seeks to decrease future violence exposure and increase resiliency of children with high levels of exposure to violence through Emergency Department (ED)-based case management and connections with community partners.

Hypothesis 1: VPET scores within the intervention group will show significant reductions across the study period. The percent of patients with positive VPET positive scores within the intervention group will show significant reductions from the expected 79% to 70% as compared to the control group that will have the expected 79%

Hypothesis 2: The Child and Youth Resilience Measure-Revised (CYRM) scores for the intervention group will increase by 10%, and will be significantly higher than the control group.

Hypothesis 3: At least 75% of the intervention group will be assessed as "positive" for having made a connection with community services.

Hypothesis 4: 90% of parents with children receiving case management will report being satisfied with the case management services and community connected services.

Hypothesis 5: Retention within the intervention group will be at or above 50%, with at least half of participants remaining engaged in the project.

Hypothesis 6: Compared to the control group, the intervention group will have fewer documented injuries and ED visits during the 12-month period post-enrollment.

Study Type

Interventional

Enrollment (Estimated)

225

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Connecticut
      • Hartford, Connecticut, United States, 06106
        • Recruiting
        • Connecticut Children's
        • Contact:
          • Sharon Smith, MD
        • Contact:
          • Kevin Borrup, DrPH

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • At least 8 years of age and not older than 17 years of age (until 18th birthday)
  • Hartford resident based on zip code of primary residence or parent report?
  • Accompanied by a parent or guardian who can provide consent
  • Capable of providing assent/consent
  • Able to provide consent in English or Spanish
  • Presenting at CT Children's during recruitment hours

Exclusion Criteria:

  • Patients whose primary complaint is for behavioral health
  • Patients in Connecticut Department of Children and Families (DCF) or police custody

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Enrolled subjects will provide the study team with email, mobile, work phone, physical contact address, and contact numbers for two or more close contacts. Families will be contacted monthly by the case manager assist with additional supports they might need. Quarterly, patients and families will be contacted and patients will be asked to complete VPET and other measures. The intervention group will receive active case management to connect affected youth to community services.
A case manager will work with families post-discharge to ensure that youth are connected to an appropriate community support. Case managers will also work with families to identify any social needs and provide support in accessing services as needed.
Subjects will receive a list of youth serving community service agencies and provided a recommendation to connect to them.
Active Comparator: Treatment as Usual
The comparison group will receive treatment as usual which consists of a list of community resources and a recommendation that youth not already connected with a community service provider be connected.
Subjects will receive a list of youth serving community service agencies and provided a recommendation to connect to them.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline violence exposure at 12 months
Time Frame: Baseline and months 3, 6, 9, and 12
A reduction in exposure as measured using the Violence Prevention Emergency Tool (VPET) that provides a range from 0 to 21 with a 4 or more considered elevated.
Baseline and months 3, 6, 9, and 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in resilience score from baseline at 12 months
Time Frame: Baseline and months 3, 6, 9, and 12
The Child and Youth Resilience Measure-Revised (CYRM) is a validated scale with resilience scores that range from 17 to 85 with a higher score indicating greater resilience.
Baseline and months 3, 6, 9, and 12
Difference in connections between intervention and control at 3-month intervals.
Time Frame: Quarterly measure at 0, 3, 6, 9, and 12 months
A dichotomous yes/no variable answering the question of are you currently connected to services at a community agency?
Quarterly measure at 0, 3, 6, 9, and 12 months
Level of satisfaction with case management services after 12 months of services
Time Frame: At 12-months of case management.
Level of satisfaction with case management services as indicated along a 5-point scale from Not satisfied to Completely satisfied. Higher levels of satisfaction are related with other improved outcomes from baseline.
At 12-months of case management.
Rate of re-injury in the intervention group compared to the control condition.
Time Frame: baseline, 3, 6, 9, 12 months
Hospital documented injuries during the study period will be assessed on a quarterly schedule.
baseline, 3, 6, 9, 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Kevin Borrup, DrPH, Connecticut Children's

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 19, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

May 29, 2024

First Submitted That Met QC Criteria

May 29, 2024

First Posted (Actual)

June 4, 2024

Study Record Updates

Last Update Posted (Estimated)

September 25, 2025

Last Update Submitted That Met QC Criteria

September 24, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 24-052

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe